Schedule 13G ownership disclosure

Cullinan Therapeutics Inc

Security class unavailable · CUSIP: 230031106

Event date: 2021-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,731,410
Percent of class
6.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-004403
Form type
SC 13G
Filer
Cullinan Therapeutics, Inc.
CIK
CIK 1789972
Filed
Jan 15, 2021
Reporting period
Jan 08, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub